InterVenn is Changing the Way the World Deals With Cancer and Other Diseases

Combining Mass Spectrometry and Artificial Intelligence to Unlock Glycoproteomics for Biomarker and Target Discovery.

Glycoproteomics: Familiar and Unfamiliar

Think of glycans as sugar molecules that are “accessories” to specific peptides - like knobs and switches that change the function and conformation of proteins. Glycosylation is involved in many aspects of human growth and development, but aberrant glycosylation has adverse effects on human physiological conditions and accompanies many diseases.

Identifying these changes at a nascent state of disease will lead to early intervention and aid in treatment decisions, with great potential to increase patient survival.

More about Glycoproteomics »


Hey! Just letting you know we use cookies. We use cookies to improve your browsing experience. By continuing to browse this site, you agree to our privacy policy and use of cookies.